These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34423788)

  • 1. The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease.
    Yang Z; Smalling RV; Huang Y; Jiang Y; Kusumanchi P; Bogaert W; Wang L; Delker DA; Skill NJ; Han S; Zhang T; Ma J; Huda N; Liangpunsakul S
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver.
    Yang Z; Tsuchiya H; Zhang Y; Lee S; Liu C; Huang Y; Vargas GM; Wang L
    Am J Pathol; 2016 Nov; 186(11):2909-2920. PubMed ID: 27664470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability.
    Ni Y; Zhao Y; Ma L; Wang Z; Ni L; Hu L; Fu Z
    Metabolism; 2021 Jan; 114():154409. PubMed ID: 33096076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha.
    Duez H; van der Veen JN; Duhem C; Pourcet B; Touvier T; Fontaine C; Derudas B; Baugé E; Havinga R; Bloks VW; Wolters H; van der Sluijs FH; Vennström B; Kuipers F; Staels B
    Gastroenterology; 2008 Aug; 135(2):689-98. PubMed ID: 18565334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
    Yuan X; Dong D; Li Z; Wu B
    Pharmacol Res; 2019 Mar; 141():310-318. PubMed ID: 30639375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
    Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
    Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
    [No Abstract]   [Full Text] [Related]  

  • 8. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway.
    Kim K; Kim JH; Kim I; Seong S; Kim N
    Mol Cells; 2020 Jan; 43(1):34-47. PubMed ID: 31896234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition.
    Ronis MJ; Korourian S; Zipperman M; Hakkak R; Badger TM
    J Nutr; 2004 Apr; 134(4):904-12. PubMed ID: 15051845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of Dual-Specificity Phosphatase 6 Protects against Nonalcoholic Fatty Liver Disease via Cytochrome P450 4A and Mitogen-Activated Protein Kinase.
    Jiang C; Saiki Y; Hirota S; Iwata K; Wang X; Ito Y; Murakami K; Imura T; Inoue J; Masamune A; Hirayama A; Goto M; Furukawa T
    Am J Pathol; 2023 Dec; 193(12):1988-2000. PubMed ID: 37741451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REV-ERB
    Zhang T; Zhao M; Lu D; Wang S; Yu F; Guo L; Wen S; Wu B
    Drug Metab Dispos; 2018 Mar; 46(3):248-258. PubMed ID: 29237721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II Suppresses Rev-erbα Expression in THP-1 Macrophages via the Ang II Type 1 Receptor/Liver X Receptor α Pathway.
    Wang S; Gu X; Zhang Q; Zhang X; Li Y; Yao Y; Yu B; Zhang Y
    Cell Physiol Biochem; 2018; 46(1):303-313. PubMed ID: 29590657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle.
    Amador A; Campbell S; Kazantzis M; Lan G; Burris TP; Solt LA
    PLoS One; 2018; 13(5):e0196787. PubMed ID: 29723273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
    Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
    IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced ethanol catabolism in orphan nuclear receptor SHP-null mice.
    Park JE; Lee M; Mifflin R; Lee YK
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G799-807. PubMed ID: 26968209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF6 and Rev-erbα integrate hepatic lipid metabolism by overlapping and distinct transcriptional mechanisms.
    Zhang Y; Fang B; Damle M; Guan D; Li Z; Kim YH; Gannon M; Lazar MA
    Genes Dev; 2016 Jul; 30(14):1636-44. PubMed ID: 27445394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBα complex.
    Berthier A; Vinod M; Porez G; Steenackers A; Alexandre J; Yamakawa N; Gheeraert C; Ploton M; Maréchal X; Dubois-Chevalier J; Hovasse A; Schaeffer-Reiss C; Cianférani S; Rolando C; Bray F; Duez H; Eeckhoute J; Lefebvre T; Staels B; Lefebvre P
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11033-E11042. PubMed ID: 30397120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.